Tirzepatide is the first dual GIP and GLP-1 drug cleared to cut major cardiovascular events, backed by the head-to-head SURPASS-CVOT trial.
Recap by typeshit. Full story at Pharmacy Times.
BMO's Evan Seigerman expects US share losses to weigh on Ozempic sales, while the 25% CagriSema figure comes from a post-hoc subgroup, not the full trial's 22.7%.
Beauty companies are reportedly exploring products aimed at facial changes linked to rapid weight loss on GLP-1 drugs.
A search page for retatrutide news with no specific story attached, so there is little new beyond recent coverage.
2:06:48
A live Q&A stream from DOWNSIZED taking viewer questions about GLP-1 medications, including Zepbound, Wegovy and Foundayo.
Researchers at the American Academy of Ophthalmology meeting found NAION patients on GLP-1 drugs tended to develop it in the other eye sooner.
In mice, GLP-1 receptor signaling mainly calmed inflammation while GLP-2 receptor signaling helped the intestine repair after T cell attack, researchers report.
Loading…